Dementia News and Research

Latest Dementia News and Research

Daytime sleepiness may double dementia risk in elderly women

For women in their 80s, experiencing increasing sleepiness during the day over a five-year period is associated with double the risk of developing dementia during that time, according to a study published on March 19, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.

20 Mar 2025

Experimental drug shows promise in reducing risk of Alzheimer's-related dementia

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis.

19 Mar 2025

Older immigrants and immigrants with dementia face interconnected barriers to social and medical services in Finland

A recent study by the University of Eastern Finland shows that barriers to accessing social and medical services among older immigrants and immigrants with dementia in Finland are interconnected.

19 Mar 2025

Most in-depth simulation of brain metabolism yet reveals new targets for future dementia treatments

The findings come from the most comprehensive computer model of brain metabolism to date, which incorporates more than 16,800 biochemical interactions between proteins and chemicals across brain cells, supporting cells, and the blood.

19 Mar 2025

Alzheimer's-modifying drug lecanemab's effectiveness may vary between genders

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

18 Mar 2025

Study: Witnessing trauma triggers unique brain changes

For years, post-traumatic stress disorder (PTSD) has been studied primarily in people who experience trauma firsthand.

18 Mar 2025

Probiotic drink kefir shows promise in preventing Alzheimer’s

Kefir, a probiotic-rich fermented milk, shows potential in reducing neuroinflammation, oxidative stress, and beta-amyloid buildup, suggesting a role in Alzheimer’s prevention and management. However, more clinical trials are needed to confirm its effectiveness in human patients.

17 Mar 2025

IL-12 targeting could open pathways for new Alzheimer's treatments

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease.

17 Mar 2025

Better heart health slows brain aging and lowers dementia risk, study finds

A JAMA Network Open study finds that better cardiovascular health (CVH) in older adults is linked to lower levels of neurodegenerative biomarkers, particularly neurofilament light chain (NfL). These benefits are consistent across races and especially impactful for individuals carrying Alzheimer's-related genetic risks.

16 Mar 2025

COVID-19 cut millions of healthy life years across Europe, study shows

The COVID-19 pandemic caused a staggering 16.8 million person-years of life lost across 18 European countries, with nearly 60% of those years expected to be lived without disability. The research highlights both direct COVID-19 deaths and indirect impacts like healthcare disruptions and rising non-COVID mortality.

16 Mar 2025

New scientific clue could unlock key cellular pathway leading to neurodegenerative diseases

In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease, and the progressive damage to the brain's frontal and temporal lobes in frontotemporal degeneration (FTD) and the associated disease amyotrophic lateral sclerosis (ALS).

14 Mar 2025

University of Minnesota awarded NIH grant for Alzheimer's cell therapy development

A University of Minnesota research team was recently awarded a five-year, $3.8 million grant from the U.S. National Institutes of Health to develop a new cell therapy to combat Alzheimer's disease.

14 Mar 2025

Fighting cancer, inflammation and unlocking dementia diagnostics

In recognition of their discovery of one of our immune system’s foundations, physician Andrea Ablasser, virologist Glen Barber and biochemist Zhijian J. Chen will be awarded the Paul Ehrlich and Ludwig Darmstaedter Prize 2025, endowed with €120,000, in Frankfurt’s Paulskirche today.

14 Mar 2025

Computational framework protects privacy in voice-based cognitive health assessments

Digital voice recordings contain valuable information that can indicate an individual's cognitive health, offering a non-invasive and efficient method for assessment.

14 Mar 2025

Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.

14 Mar 2025

Modified tool helps assess symptoms in cognitively impaired nursing home residents

As many as half of nursing home residents are cognitively impaired and may be unable to communicate symptoms such as pain or anxiety to the staff and clinicians caring for them.

14 Mar 2025

Portable system detects mild cognitive impairment in older adults

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes.

13 Mar 2025

Dementia risk higher among adults with HIV in Malawi

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according to a new study by a team of US and Malawian researchers.

12 Mar 2025

Sent home to heal, patients avoid wait for rehab home beds

After a patch of ice sent Marc Durocher hurtling to the ground, and doctors at UMass Memorial Medical Center repaired the broken hip that resulted, the 75-year-old electrician found himself at a crossroads.

12 Mar 2025

COVID-19 pandemic caused significant loss of disability-free life in Europe

Among 289 million adults in 18 European countries, more than 16 million years of life were lost from 2020 through 2022 due to the COVID-19 pandemic, according to a new study published March 11th in the open-access journal PLOS Medicine by Sara Ahmadi-Abhari of Imperial College London, UK, and colleagues.

11 Mar 2025

Dementia News and Research

Latest Dementia News and Research

Daytime sleepiness may double dementia risk in elderly women

Experimental drug shows promise in reducing risk of Alzheimer's-related dementia

Older immigrants and immigrants with dementia face interconnected barriers to social and medical services in Finland

Most in-depth simulation of brain metabolism yet reveals new targets for future dementia treatments

Alzheimer's-modifying drug lecanemab's effectiveness may vary between genders

Study: Witnessing trauma triggers unique brain changes

Probiotic drink kefir shows promise in preventing Alzheimer’s

IL-12 targeting could open pathways for new Alzheimer's treatments

Better heart health slows brain aging and lowers dementia risk, study finds

COVID-19 cut millions of healthy life years across Europe, study shows

New scientific clue could unlock key cellular pathway leading to neurodegenerative diseases

University of Minnesota awarded NIH grant for Alzheimer's cell therapy development

Fighting cancer, inflammation and unlocking dementia diagnostics

Computational framework protects privacy in voice-based cognitive health assessments

Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston

Modified tool helps assess symptoms in cognitively impaired nursing home residents

Portable system detects mild cognitive impairment in older adults

Dementia risk higher among adults with HIV in Malawi

Sent home to heal, patients avoid wait for rehab home beds

COVID-19 pandemic caused significant loss of disability-free life in Europe

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Dementia News and Research

Latest Dementia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in